Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23094
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSeymour, John F-
dc.contributor.authorMarcus, Robert-
dc.contributor.authorDavies, Andrew-
dc.contributor.authorGallop-Evans, Eve-
dc.contributor.authorGrigg, Andrew P-
dc.contributor.authorHaynes, Andrew-
dc.contributor.authorHerold, Michael-
dc.contributor.authorIllmer, Thomas-
dc.contributor.authorNilsson-Ehle, Herman-
dc.contributor.authorSökler, Martin-
dc.contributor.authorDünzinger, Ulrich-
dc.contributor.authorNielsen, Tina-
dc.contributor.authorLaunonen, Aino-
dc.contributor.authorHiddemann, Wolfgang-
dc.date.accessioned2020-05-05T23:59:23Z-
dc.date.available2020-05-05T23:59:23Z-
dc.date.issued2020-05-
dc.identifier.citationHaematologica 2020; 105(5): 1465-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/23094-
dc.language.isoeng-
dc.titleAssociation of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.-
dc.typeJournal Article-
dc.identifier.journaltitleHaematologica-
dc.identifier.affiliationPeter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Victoria, Australiaen
dc.identifier.affiliationKings College Hospital, London, UK-
dc.identifier.affiliationF. Hoffmann-La Roche Ltd., Basel, Switzerlanden
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationCancer Research UK Centre, University of Southampton, Southampton, UK-
dc.identifier.affiliationVelindre Cancer Centre, Cardiff, UK-
dc.identifier.affiliationNottingham University Hospitals NHS Trust, Nottingham, UK-
dc.identifier.affiliationHELIOS-Klinikum Erfurt, Germany-
dc.identifier.affiliationBAG Freiberg-Richter, Jacobasch, Illmer and Wolf, Dresden, Germany-
dc.identifier.affiliationSection of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden-
dc.identifier.affiliationEberhard-Karls-University Tübingen, Tübingen, Germany-
dc.identifier.affiliationRoche Pharma AG, Grenzach-Wyhlen, Germany-
dc.identifier.affiliationDepartment of Medicine III, Ludwig-Maximilians-University, München, Germany-
dc.identifier.doi10.3324/haematol.2020.246991-
dc.identifier.pubmedid32358081-
dc.type.austinJournal Article-
dc.type.austinPublished Erratum-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Jan 15, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.